Affiliations 

  • 1 Princess Margaret Hospital Hong Kong Special Administrative Region China
  • 2 Agnes Ginges Centre for Molecular Cardiology Centenary Institute Sydney Australia
  • 3 Division of Electrophysiology Philippine Heart Center Manila Philippines
  • 4 Cardiology Department Tauranga Hospital Tauranga New Zealand
  • 5 Division of Cardiology Department of Medicine Taipei Veterans General Hospital Taipei Taiwan
  • 6 Consultant Cardiologist Head of Cardiology RIPAS Hospital Bandar Seri Begawan Brunei Darussalam
  • 7 Cardiology Unit Townsville University Hospital Townsville Australia
  • 8 Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea
  • 9 Department of Cardiology Hospital Sultanah Bahiyah Alor Setar Kedah Malaysia
  • 10 Division of Cardiology Department of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
  • 11 Division of Cardiology Department of Medicine Nihon University School of Medicine Tokyo Japan
  • 12 Department of Medicine Queen Mary Hospital The University of Hong Kong Hong Kong Special Administrative Region China
  • 13 National University Hospital National University Heart Centre Singapore
  • 14 Vietnam National Heart Institute Hanoi Vietnam
  • 15 Division of Cardiology Care Institute of Medical Sciences Hospital Ahmedabad India
  • 16 Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan
  • 17 Melbourne Brain Centre University of Melbourne Melbourne Australia
  • 18 Department of Cardiology and Vascular Medicine Faculty of Medicine Universitas Indonesia, and National Cardiovascular Center Harapan Kita Jakarta Indonesia
  • 19 Department of Cardiology Yangon General Hospital University of Medicine Yangon Myanmar
  • 20 HMC Peshawar Pakistan
  • 21 Wuhan University Renmin Hospital Wuhan China
  • 22 Charles Perkins Centre The University of Sydney Sydney Australia
J Arrhythm, 2022 Feb;38(1):31-49.
PMID: 35222749 DOI: 10.1002/joa3.12669

Abstract

In this paper, the Asia Pacific Heart Rhythm Society (APHRS) sought to provide practice guidance on AF screening based on recent evidence, with specific considerations relevant to the Asia-Pacific region. A key recommendation is opportunistic screening for people aged ≥65 years (all countries), with systematic screening to be considered for people aged ≥75 years or who have additional risk factors (all countries).

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.